10 recruiting, 8 completed, 4 unknown, 2 active not recruiting. 6 Not applicable, 3 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 2, Unknown 2, Active not recruiting 1, Recruiting 1 |
| Phase 3 | 3 | Recruiting 2, Terminated 1 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Cardiovascular Events: new trials by email Literature Review of Cardiovascular Events trials Research Report on Cardiovascular Events
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statins to Prevent Cancer Associated Blood Clots Rosuvastatin, Placebo Drug - Venous Thromboembolism, Cancer | Phase 4 | Recruiting | Brigham and Women's Hospital | 4000 | 2026-06-11 | 2026-09-16 |
| Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy Aspirin 80mg, Placebo Oral Tablet - Myocardial Infarction (MI), Cardiovascular Events | Phase 3 | Recruiting | Chinese University of Hong Kong | 2514 | 2026-02-10 | 2026-03-18 |
| Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cell Transplantation, Transplant Complication | Recruiting | Peking University People's Hospital | 10000 | 2026-01-01 | 2026-01-16 | |
| Tezspire Cardiac Events PASS Tezepelumab - Cardiovascular Events, MACE | Recruiting | AstraZeneca | 16640 | 2025-09-15 | 2026-09-18 | |
| Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography PCSK9 inhibitors and background lipid-modifying therapy, Standard lipid-modifying therapy - Coronary Artery Disease, CT Angiography | Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 3596 | 2025-04-22 | 2026-02-06 |
| Colchicine in Chronic Kidney Disease Patients colchicine treatment in chronic kidney disease patients, placebo treatment - Chronic Kidney Disease, Cardiovascular Events | Phase 3 | Recruiting | Hospital General Universitario Gregorio Marañon | 744 | 2025-02-12 | 2025-05-31 |
| The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease Pharmacological treatment - COPD, COPD Exacerbation Acute | Enrolling by invitation | University of Milan | 10000 | 2024-09-30 | 2026-05-04 | |
| Evaluation of Vulnerability of Carotid Plaques and Prediction of Cardio-Cerebrovascular Event Using Ultrasonic Imaging Cardiovascular and cerebrovascular diseases - Carotid Plaque, Ischemic Stroke | Recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 600 | 2024-07-01 | 2024-12-06 | |
| Weight Management of Dialysis Patients Family weight self-measurement and remote follow-up management based on wechat., Routine care - Hemodialysis, Life Quality | Not applicable | Unknown | qinxiu zhang | 100 | 2024-04-01 | 2024-03-27 |
| Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4), High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4) - Influenza, Community-acquired Pneumonia | Recruiting | Kaiser Permanente | 1500000 | 2023-08-17 | 2026-08-05 | |
| Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD Hepatologic-provided recommendations, Nutritional support, Psychological support - MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD | Not applicable | Completed | University of Campania Luigi Vanvitelli | 286 | 2023-07-01 | 2026-02-12 |
| PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI Placebo plus high-intensity statin, PCSK 9 Inhibitor plus high-intensity statin - Acute Coronary Syndrome, Hyperlipidemias | Not applicable | Active not recruiting | Nanjing First Hospital, Nanjing Medical University | 1212 | 2023-03-30 | 2026-07-21 |
| Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity Arteriosclerosis, Acute Myocardial Infarction | Recruiting | Heinrich-Heine University, Duesseldorf | 180 | 2022-03-07 | 2023-08-14 | |
| Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study SGLT2 inhibitor, DPP-4 inhibitor, GLP-1RA - Cardiovascular Events, Type2 Diabetes | Active not recruiting | Brigham and Women's Hospital | 781430 | 2021-08-01 | 2026-08-13 | |
| Addiction in Intensive Cardiac Care Units urine test, Fagerström questionnaire, Exhaled carbon monoxide (CO) measurement - Intensive Care Unit Syndrome, Drug Abuse | Unknown | Assistance Publique - Hôpitaux de Paris | 1500 | 2021-04-06 | 2023-04-18 | |
| Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA Carotid Artery Reactivity test (CAR test), Arterial Stiffness - Abdominal Aortic Aneurysm, Cardiovascular Events | Recruiting | Rijnstate Hospital | 194 | 2020-06-12 | 2025-03-06 | |
| Tonometry and Duplex Ultrasound to Predict AAA Progression and CV Events in Aneurysm Patients (1-2-3 Trial) Carotid Artery Reactivity test (CAR test), Arterial stiffness - Abdominal Aortic Aneurysm, Cardiovascular Events | Completed | Rijnstate Hospital | 167 | 2019-07-01 | 2024-04-11 | |
| Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Chinese Population No intervention in this study - Blood Pressure, Cardiovascular Risk Factor | Unknown | Shanghai 10th People's Hospital | 3000 | 2017-06-01 | 2017-08-21 | |
| Post-stroke Depression Treatment Effect on Stroke Recurrence Citalopram - Stroke Recurrence, Cardiovascular Events | Not applicable | Completed | Ege University | 1230 | 2017-02-11 | 2021-03-01 |
| Incidence and Prognostic Implication of Acute CV Events in Patients Hospitalized for CAP in Internal Medicine Units. No intervention - Cardiovascular Events | Completed | Fadoi Foundation, Italy | 1266 | 2016-10-01 | 2019-01-10 |
Showing 20 of 26. Sign in to see all of them.
Acute Coronary Syndrome (2) · Aortic Aneurysm, Abdominal (2) · Community-Acquired Pneumonia (2) · Coronary Artery Disease (2) · Heart Failure (2) · Myocardial Infarction (2) · Arteriosclerosis (1) · Atherosclerosis (1) · Bronchitis, Chronic (1) · Cardiovascular Diseases (1) · Coitus (1) · Depression (1) · Emphysema (1) · Heart Diseases (1) · Hyperlipidemias (1)
Cardiovascular Diseases (13) · Vascular Diseases (12) · Heart Diseases (7) · Myocardial Ischemia (6) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Respiratory Tract Diseases (4) · Arterial Occlusive Diseases (3) · Infections (3) · Respiratory Tract Infections (3) · Aneurysm (2) · Aortic Aneurysm (2) · Aortic Diseases (2) · Arteriosclerosis (2) · Behavior (2)
Vascular Stiffness (2) · Amlodipine (1) · Aspirin (1) · Blood Circulation (1) · Calcium Carbonate (1) · Canagliflozin (1) · Citalopram (1) · Cognitive Behavioral Therapy (1) · Comorbidity (1) · Dipeptidyl-Peptidase IV Inhibitors (1) · Drug Therapy (1) · Exenatide (1) · Fluzone High-Dose (1) · Glipizide (1) · Glyburide (1)
AstraZeneca (2) · Brigham and Women's Hospital (2) · Rijnstate Hospital (2) · Assistance Publique - Hôpitaux de Paris (1) · Chinese University of Hong Kong (1) · Chugai Pharma Taiwan (1) · Clinic Roderbirken (1) · Ege University (1) · Fadoi Foundation, Italy (1) · Heinrich-Heine University, Duesseldorf (1) · Hospital General Universitario Gregorio Marañon (1) · Kaiser Permanente (1) · Kyoto University (1) · Nanjing First Hospital, Nanjing Medical University (1) · Novartis Pharmaceuticals (1)
China (5) · United States (5) · Germany (4) · Netherlands (3) · France (2) · Italy (2) · Japan (2) · Spain (2) · Argentina (1) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · Czechia (1) · Denmark (1)
Bon-Kwon Koo (1) · Chiu-Ching Huang, Professor (1) · Elisabetta Patorno, MD, DrPH (1) · Gualberto Gussoni, MD (1) · James Yun Wong Lau, MD (1) · Malte Kelm, Prof. (1) · Masato Nishimura, MD (1) · Masunori Matsuzaki, MD, PhD (1) · Michel Reijnen, MD, prof (1) · Michel Rijnen, MD, prof (1) · Peter Egger (1) · Rong Wu, Dr (1)
PMID 11786451, PMID 20150346, PMID 21873632, PMID 22451449, PMID 22661458, PMID 24616335, PMID 24679062, PMID 24999798, PMID 25391758, PMID 25975531, PMID 26304958, PMID 27007989, PMID 28753697, PMID 33494707, PMID 34362780, PMID 34632437, PMID 35028736, PMID 37582633, PMID 38261914, PMID 38381068, PMID 38428980, PMID 38650518, PMID 38670139, PMID 38834393, PMID 39910544, PMID 40110211, PMID 40110223, PMID 40396434, PMID 40576086, PMID 41697269, PMID 42081247, PMID 42805146
2009 (1), 2023 (1), UG3HL176627 (1)